Search Results - "Chuantao Zuo"

Individual brain metabolic connectome indicator based on Kullback-Leibler Divergence Similarity Estimation predicts progression from mild cognitive impairment to Alzheimer’s dementia by Wang, Min, Jiang, Jiehui, Yan, Zhuangzhi, Alberts, Ian, Ge, Jingjie, Zhang, Huiwei, Zuo, Chuantao, Yu, Jintai, Rominger, Axel, Shi, Kuangyu

“…Purpose Positron emission tomography (PET) with 18 F-fluorodeoxyglucose (FDG) reveals altered cerebral metabolism in individuals with mild cognitive impairment…”
Get full text

PET Neuroimaging of Alzheimer's Disease: Radiotracers and Their Utility in Clinical Research by Bao, Weiqi, Xie, Fang, Zuo, Chuantao, Guan, Yihui, Huang, Yiyun Henry

“…Alzheimer's Disease (AD), the leading cause of senile dementia, is a progressive neurodegenerative disorder affecting millions of people worldwide and exerting…”
Get full text

Consistent abnormalities in metabolic network activity in idiopathic rapid eye movement sleep behaviour disorder by PING WU, HUAN YU, SHICHUN PENG, DAUVILLIERS, Yves, JIAN WANG, JINGJIE GE, HUIWEI ZHANG, EIDELBERG, David, YILONG MA, CHUANTAO ZUO

“…Rapid eye movement sleep behaviour disorder has been evaluated using Parkinson's disease-related metabolic network. It is unknown whether this disorder is…”
Get full text

Using radiomics-based modelling to predict individual progression from mild cognitive impairment to Alzheimer’s disease by Jiang, Jiehui, Wang, Min, Alberts, Ian, Sun, Xiaoming, Li, Taoran, Rominger, Axel, Zuo, Chuantao, Han, Ying, Shi, Kuangyu, Initiative, for the Alzheimer’s Disease Neuroimaging

“…Background Predicting the risk of disease progression from mild cognitive impairment (MCI) to Alzheimer’s disease (AD) has important clinical significance…”
Get full text

Radiomics: a novel feature extraction method for brain neuron degeneration disease using 18F-FDG PET imaging and its implementation for Alzheimer’s disease and mild cognitive impairment by Li, Yupeng, Jiang, Jiehui, Lu, Jiaying, Jiang, Juanjuan, Zhang, Huiwei, Zuo, Chuantao

“…Background: Alzheimer’s disease (AD) is the most common form of progressive and irreversible dementia, and accurate diagnosis of AD at its prodromal stage is…”
Get full text

Radiomics: a novel feature extraction method for brain neuron degeneration disease using F-FDG PET imaging and its implementation for Alzheimer’s disease and mild cognitive impairment by Yupeng Li, Jiehui Jiang, Jiaying Lu, Juanjuan Jiang, Huiwei Zhang, Chuantao Zuo

“…Background: Alzheimer’s disease (AD) is the most common form of progressive and irreversible dementia, and accurate diagnosis of AD at its prodromal stage is…”
Get full text

Predicting Alzheimer Disease From Mild Cognitive Impairment With a Deep Belief Network Based on 18F-FDG-PET Images by Shen, Ting, Jiang, Jiehui, Lu, Jiaying, Wang, Min, Zuo, Chuantao, Yu, Zhihua, Yan, Zhuangzhi

“…Objective: Accurate diagnosis of early Alzheimer disease (AD) plays a critical role in preventing the progression of memory impairment. We aimed to develop a…”
Get full text

Detection of individual brain tau deposition in Alzheimer's disease based on latent feature-enhanced generative adversarial network by Jiang, Jiehui, Shi, Rong, Lu, Jiaying, Wang, Min, Zhang, Qi, Zhang, Shuoyan, Wang, Luyao, Alberts, Ian, Rominger, Axel, Zuo, Chuantao, Shi, Kuangyu

“…•Detection of individual brain tau deposition is important for the diagnosis of Alzheimer's disease.•The model based on the latent feature-enhanced generative…”
Get full text

Recent progress in the applications of presynaptic dopaminergic positron emission tomography imaging in parkinsonism by Yang, Yujie, Li, Xinyi, Lu, Jiaying, Ge, Jingjie, Chen, Mingjia, Yao, Ruixin, Tian, Mei, Wang, Jian, Liu, Fengtao, Zuo, Chuantao

“…Nowadays, presynaptic dopaminergic positron emission tomography, which assesses deficiencies in dopamine synthesis, storage, and transport, is widely utilized…”
Get full text

Associations of [ 18 F]-APN-1607 Tau PET Binding in the Brain of Alzheimer's Disease Patients With Cognition and Glucose Metabolism by Lu, Jiaying, Bao, Weiqi, Li, Ming, Li, Ling, Zhang, Zhengwei, Alberts, Ian, Brendel, Matthias, Cumming, Paul, Lu, Huimeng, Xiao, Zhenxu, Zuo, Chuantao, Guan, Yihui, Zhao, Qianhua, Rominger, Axel

“…Molecular imaging of tauopathies is complicated by the differing specificities and off-target binding properties of available radioligands for positron…”
Get full text

Reduced SV2A and GABAA receptor levels in the brains of type 2 diabetic rats revealed by [18F]SDM-8 and [18F]flumazenil PET by Kong, Yanyan, Cao, Lei, Xie, Fang, Wang, Xiuzhe, Zuo, Chuantao, Shi, Kuangyu, Rominger, Axel, Huang, Qi, Xiao, Jianfei, Jiang, Donglang, Guan, Yihui, Ni, Ruiqing

“…Type 2 diabetes mellitus (T2DM) is associated with a greater risk of Alzheimer's disease. Synaptic impairment and protein aggregates have been reported in the…”
Get full text

Use of Overlapping Group LASSO Sparse Deep Belief Network to Discriminate Parkinson's Disease and Normal Control by Shen, Ting, Jiang, Jiehui, Lin, Wei, Ge, Jingjie, Wu, Ping, Zhou, Yongjin, Zuo, Chuantao, Wang, Jian, Yan, Zhuangzhi, Shi, Kuangyu

“…As a medical imaging technology which can show the metabolism of the brain, 18F-fluorodeoxyglucose (FDG)-positron emission tomography (PET) is of great value…”
Get full text

PET Imaging for Dynamically Monitoring Neuroinflammation in APP/PS1 Mouse Model Using [18F]DPA714 by Hu, Wei, Pan, Donghui, Wang, Yalin, Bao, Weiqi, Zuo, Chuantao, Guan, Yihui, Hua, Fengchun, Yang, Min, Zhao, Jun

“…Background: In the pathogenesis of Alzheimer's diseases, microglia plays an increasing important role. Especially, molecular imaging of neuroinflammatory…”
Get full text

Distinct cerebral 18F-FDG PET metabolic patterns in anti-N-methyl-D-aspartate receptor encephalitis patients with different trigger factors by Ge, Jingjie, Deng, Bo, Guan, Yihui, Bao, Weiqi, Wu, Ping, Chen, Xiangjun, Zuo, Chuantao

“…Aim: Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is a subgroup of treatable autoimmune encephalitis, characterized by rapid development of…”
Get full text

Cerebral Metabolic Differences Associated with Cognitive Impairment in Parkinson's Disease by Tang, Yilin, Ge, Jingjie, Liu, Fengtao, Wu, Ping, Guo, Sisi, Liu, Zhenyang, Wang, Yixuan, Wang, Ying, Ding, Zhengtong, Wu, Jianjun, Zuo, Chuantao, Wang, Jian

“…To characterize cerebral glucose metabolism associated with different cognitive states in Parkinson's disease (PD) using 18F-fluorodeoxyglucose (FDG) and…”
Get full text

Metabolic network as an objective biomarker in monitoring deep brain stimulation for Parkinson’s disease: a longitudinal study by Ge, Jingjie, Wang, Min, Lin, Wei, Wu, Ping, Guan, Yihui, Zhang, Huiwei, Huang, Zhemin, Yang, Likun, Zuo, Chuantao, Jiang, Jiehui, Rominger, Axel, Shi, Kuangyu

“…Background With the advance of subthalamic nucleus (STN) deep brain stimulation (DBS) in the treatment of Parkinson’s disease (PD), it is desired to identify…”
Get full text

Parametric Estimation of Reference Signal Intensity for Semi-Quantification of Tau Deposition: A Flortaucipir and [ 18 F]-APN-1607 Study by Zhang, Huiwei, Wang, Min, Lu, Jiaying, Bao, Weiqi, Li, Ling, Jiang, Jiehui, Zuo, Chuantao

“…Tau positron emission tomography (PET) imaging can reveal the pathophysiology and neurodegeneration that occurs in Alzheimer's disease (AD) . The standardized…”
Get full text

Distinct cerebral F-FDG PET metabolic patterns in anti-N-methyl-D-aspartate receptor encephalitis patients with different trigger factors by Jingjie Ge, Bo Deng, Yihui Guan, Weiqi Bao, Ping Wu, Xiangjun Chen, Chuantao Zuo

“…Aim: Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is a subgroup of treatable autoimmune encephalitis, characterized by rapid development of…”
Get full text

The diagnostic value of lower glucose consumption for IDH1 mutated gliomas on FDG-PET by Liu, Feng-Min, Gao, Yu-Fei, Kong, Yanyan, Guan, Yihui, Zhang, Jinsen, Li, Shuai-Hong, Ye, Dan, Wen, Wenyu, Zuo, Chuantao, Hua, Wei

“…Non-invasive diagnosis of IDH1 mutation for gliomas has great clinical significance, and PET has natural advantage to detect metabolism, as IDH mutated gliomas…”
Get full text

International consensus on the use of tau PET imaging agent 18F-flortaucipir in Alzheimer’s disease by Tian, Mei, Civelek, A. Cahid, Carrio, Ignasi, Watanabe, Yasuyoshi, Kang, Keon Wook, Murakami, Koji, Garibotto, Valentina, Prior, John O., Barthel, Henryk, Zhou, Rui, Hou, Haifeng, Dou, Xiaofeng, Jin, Chentao, Zuo, Chuantao, Zhang, Hong

“…Purpose Positron emission tomography (PET) with the first and only tau targeting radiotracer of 18 F-flortaucipir approved by FDA has been increasingly used in…”
Get full text